"10.1371_journal.pone.0046043","plos one","2012-09-28T00:00:00Z","Qunying Mao; Chenghong Dong; Xiuling Li; Qiang Gao; Zengbing Guo; Xin Yao; Yiping Wang; Fan Gao; Fengxiang Li; Miao Xu; Weidong Yin; Qihan Li; Xinliang Shen; Zhenglun Liang; Junzhi Wang","National Institutes for Food and Drug Control, Beijing, China; Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, China; National Vaccine and Serum Institute, Beijing, China; Sinovac Biotech Co., Ltd., Beijing, China; Hualan Biological Engineering Inc, Henan, China","Conceived and designed the experiments: ZL JW WY QL XS. Performed the experiments: CD XL QG ZG XY YW FG. Analyzed the data: QM FL MX. Contributed reagents/materials/analysis tools: ZL JW. Wrote the paper: QM ZL.","Q Gao and WD Yin are affiliated to Sinovac Biotech Co., Ltd. ZB Guo is affiliated to Hualan Biological Engineering Inc.; XL Li and XL Shen are affiliated to National Vaccine and Serum Institute; CH Dong and QH Li are affiliated to Institute of Medical Biology, Chinese Academy of Medical Sciences. As a Board member, WD Yin holds shares of Sinovac Biotech Co., Ltd. There are EV71 vaccines in development to declare. There are no consultancies, patents, or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies concerning sharing data and materials as detailed online in the guide for authors.","2012","09","Qunying Mao","QM",15,TRUE,5,7,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
